Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 17.74B | 18.50B | 22.75B | 18.04B | 13.29B | 15.08B |
Gross Profit | 4.09B | 4.44B | 5.44B | 4.91B | 3.35B | 3.86B |
EBITDA | 878.03M | 1.21B | 2.66B | 2.02B | 1.17B | 1.17B |
Net Income | 377.15M | 498.44M | 906.71M | 563.75M | 126.69M | 132.00M |
Balance Sheet | ||||||
Total Assets | 25.68B | 25.88B | 25.40B | 22.05B | 19.66B | 19.03B |
Cash, Cash Equivalents and Short-Term Investments | 3.72B | 3.26B | 4.01B | 2.90B | 2.16B | 2.24B |
Total Debt | 7.27B | 6.58B | 5.50B | 4.00B | 4.54B | 4.09B |
Total Liabilities | 14.13B | 14.19B | 14.67B | 12.24B | 10.35B | 10.22B |
Stockholders Equity | 11.36B | 11.51B | 10.52B | 9.61B | 9.13B | 8.63B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -968.36M | -68.92M | 1.44B | -369.54M | -838.00M |
Operating Cash Flow | 0.00 | 427.82M | 1.35B | 2.15B | 531.23M | 436.00M |
Investing Cash Flow | 0.00 | -1.31B | -1.43B | -716.43M | -887.36M | -1.13B |
Financing Cash Flow | 0.00 | 214.68M | 1.15B | -748.14M | 315.04M | 270.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥6.20B | 9.49 | 3.13% | 6.58% | 29.17% | ||
70 Outperform | ¥18.84B | 14.86 | 3.97% | 3.18% | 2.22% | ||
70 Neutral | ¥10.31B | 11.21 | 5.18% | 6.46% | ― | ||
65 Neutral | $10.77B | 15.80 | 5.51% | 1.90% | 3.03% | -26.66% | |
57 Neutral | ¥4.60B | 13.84 | 3.50% | -10.46% | -176.78% | ||
56 Neutral | ¥5.24B | 30.37 | 2.18% | -6.59% | -65.39% | ||
56 Neutral | ¥6.98B | 132.79 | 5.87% | -2.14% | -48.88% |